Trial of Intravenous Fenretinide Emulsion for Patients With Relapsed/Refractory Peripheral T-cell Lymphomas
Clinical trial NCT02495415 · UNKNOWN
Trial details
- NCT number
- NCT02495415
- Sponsor
- CerRx, Inc.
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-12-01
- Primary completion
- 2021-07-01
- Enrollment
- 140
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.